Gene · 7045
Papers3,774
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,774
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteome and Secretome Profiling of the Melanoma-Induced Transition Toward Immune Incompetent Dendritic Cells Reveals Enhanced IDO1, Cathepsin, and Legumain Activity. | Mol Cell Proteomics | 2025 | 40789452 | PubTator, text mining | PubMed |
| Identification and validation of biomarkers associated with glycolysis in polycystic ovarian syndrome. | Sci Rep | 2025 | 40715316 | PubTator, text mining | PubMed |
| Intrinsic PDL1 Signaling Modulates TGFBI-Mediated Growth Suppression in Lung Adenocarcinoma. | Cancer Sci | 2025 | 40702751 | PubTator, text mining | PubMed |
| Integrated single-cell and spatial transcriptomics uncover distinct cellular subtypes involved in neural invasion in pancreatic cancer. | Cancer Cell | 2025 | 40680743 | PubTator, text mining | PubMed |
| Rare TGFBI Mutation c.1553T>G p.(L518R) in Lattice Corneal Dystrophy: Comprehensive Clinical and Genetic Analysis in a Chinese Family. | Am J Ophthalmol | 2025 | 40669590 | PubTator, text mining | PubMed |
| Genetic epidemiology of epithelial-stromal TGFBI dystrophies in a large Korean population. | Sci Rep | 2025 | 40659714 | PubTator, text mining | PubMed |
| DNA methylation and hydroxymethylation combined with transcriptional profiling identify key regulators of hyperoxia-induced bronchopulmonary dysplasia. | Clin Epigenetics | 2025 | 40616194 | PubTator, text mining | PubMed |
| Combined transcriptomics and proteomics analysis reveals mechanisms underlying refractory lupus nephritis in children. | Clin Rheumatol | 2025 | 40613967 | PubTator, text mining | PubMed |
| Identification of parthanatos-related molecular subtypes and development of prognostic risk models in ovarian cancer based on multi-omics analysis. | J Ovarian Res | 2025 | 40605104 | PubTator, text mining | PubMed |
| Integrative analysis using machine learning and RNA sequencing identifies TGFBI as a therapeutic target in HIV-associated osteonecrosis of the femoral head. | Int J Biol Macromol | 2025 | 40582670 | PubTator, text mining | PubMed |
| A case of paternity-confirmed de novo R124H mutation resulting in granular corneal dystrophy type 2. | Ophthalmic Genet | 2025 | 40556321 | PubTator, text mining | PubMed |
| Immunological biomarkers and gene signatures predictive of radiotherapy resistance in non-small cell lung cancer. | Front Immunol | 2025 | 40510341 | PubTator, text mining | PubMed |
| Role of TGFβ-activated cancer-associated fibroblasts in the resistance to checkpoint blockade immunotherapy. | Front Oncol | 2025 | 40469190 | PubTator, text mining | PubMed |
| Mechanism of Curcumol Targeting the OTUB1/TGFBI Ubiquitination Pathway in the Inhibition of Angiogenesis in Colon Cancer. | Int J Mol Sci | 2025 | 40430059 | PubTator, text mining | PubMed |
| Transcriptomic profiling and bioinformatics-driven statistical prioritization of CRC biomarkers: A step toward precision oncology. | Gene | 2025 | 40419032 | PubTator, text mining | PubMed |
| Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in patients with advanced pancreatic ductal adenocarcinoma. | BMC Cancer | 2025 | 40394523 | PubTator, text mining | PubMed |
| Immune Regulation and Disulfidptosis in Atherosclerosis Influence Disease Progression and Therapy. | Biomedicines | 2025 | 40299531 | PubTator, text mining | PubMed |
| Descemet's Membrane Detachment During Cataract Surgery in Lattice Corneal Dystrophy Type I: Histopathological Analysis of Posterior Corneal Involvement. | Cureus | 2025 | 40296953 | PubTator, text mining | PubMed |
| TGFBI promotes EMT and perineural invasion of pancreatic cancer via PI3K/AKT pathway. | Med Oncol | 2025 | 40286004 | PubTator, text mining | PubMed |
| Exomeres and supermeres: Current advances and perspectives. | Bioact Mater | 2025 | 40276541 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7045/papers?page=7